Bruker Announces Acquisition of MERLIN Diagnostika GmbH

Bruker has announced the completion of its acquisition of MERLIN Diagnostika GmbH, located near Bonn, Germany.  MERLIN has in-depth expertise in products, services and consulting in the fields of antibiotic resistance testing (ART) and antibiotic susceptibility testing (AST). Bruker claims that MERLIN’s technology and product portfolio will further expand thier microbiology business, which is based on rapid, broad-based microbial identification using Bruker’s market-leading MALDI Biotyper (MBT) platform for proteomic fingerprinting.  Financial details were not disclosed.

Read on…